Moleculin Biotech MBRX
NASDAQ MBRX
$0.60 +0.00 (+0.75%)
As of: Aug 21, 2026 · 11:20 AM EDT

Moleculin Biotech (MBRX) Short term Debt (2019 - 2022)

Moleculin Biotech (MBRX) posted quarterly Short term Debt of $86000.0 for Q4 2022, down 21.1% year-over-year from $109000.0 in Q4 2021, and down 21.82% quarter-over-quarter from $110000.0 in Q3 2022.

Moleculin Biotech (MBRX) Short term Debt (2019 - 2022) Analysis & Trends

Moleculin Biotech's Short term Debt history runs 4 years deep, the most recent figure standing at $86000.0 for Q4 2022.

  • In Q4 2022, Short term Debt fell 21.1% year-over-year to $86000.0; the TTM figure through Dec 2022 stood at $86000.0 (down 21.1% YoY), while the FY2022 annual figure was $86000.0, down 21.1% from the prior year.
  • Short term Debt for Q4 2022 stood at $86000.0, down from $110000.0 in the prior quarter.
  • The five-year high for Short term Debt was $124000.0 in Q1 2022, with the low at $78000.0 in Q4 2020.
  • The 4-year median for Short term Debt is $99000.0 (2019), against an average of $99444.4.
  • The sharpest annual moves came in 2020 and 2021: Short term Debt fell 21.21% in 2020, then surged 39.74% in 2021.
  • Moleculin Biotech's Short term Debt stood at $99000.0 in 2019, then slipped by 21.21% to $78000.0 in 2020, then soared by 39.74% to $109000.0 in 2021, then slipped by 21.1% to $86000.0 in 2022.
  • Business Quant data shows MBRX's Short term Debt at $86000.0 in Q4 2022, $110000.0 in Q3 2022, and $95000.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.97 Bn 132.12 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.64 Bn 78.64 Bn 3.93 Bn
3 Argenx Se 65.55 Bn 60.37 Bn 1.37 Bn
4 Moderna 61.26 Bn 56.12 Bn 52.00 Mn
5 BeOne Medicines 42.30 Bn 37.20 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.66 Bn 28.35 Bn 992.69 Mn
7 BioNTech SE 28.68 Bn 10.29 Bn 668.28 Mn
8 Insmed 27.54 Bn 26.38 Bn 358.27 Mn
9 Royalty Pharma 27.26 Bn 26.42 Bn -
10 Moleculin Biotech 3.38 Mn 3.38 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 86,000.00
Sep 30, 2022 110,000.00
Jun 30, 2022 95,000.00
Mar 31, 2022 124,000.00
Dec 31, 2021 109,000.00
Mar 31, 2021 95,000.00
Dec 31, 2020 78,000.00
Sep 30, 2020 99,000.00
Dec 31, 2019 99,000.00